Drug may prevent lung cancer, study finds.
The drug, called Iloprost, is approved in inhaled forms to treat pulmonary hypertension, when blood pools near the lungs, a connective tissue disease called scleroderma and a nerve condition called Raynaud's phenomenon. Oral iloprost showed promise for preventing lung cancer in former, but not current, smokers in a phase II clinical trial. Maggie Fox. Reuters. 05/18/10. (Also see: Iloprost)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Drug may prevent lung cancer, study finds
No replies to this topic